Telangana Anti-Narcotics Bureau Seals Alprazolam Manufacturing Unit

Hyderabad: Gosukonda Anji Reddy, 41, owner of Chandra Reddy Garden, and Gummadidala Swimming pool, in Gummadidala, and Kyasaram Rakesh, 36, a realtor, were arrested after a contraband manufacturing lab was discovered on their premises in Sangareddy.

The Telangana Anti-Narcotics Bureau (TGANB) officials seized 2.6 kilograms of contraband along with the manufacturing lab and the equipment used. About 20 kilograms of stage-1 intermediate product, 10 kilograms of stage-2 intermediate produce, 350 litres of mixed solution, 35 kilograms of hexamethyl antihistamine, 16 litres of acetic acid, one barrel of ammonium carbonate, and 90 kilograms of phosphorous penta sulphide were also seized.

According to officials, the two arrested were suppliers to a network of drugs comprising Prabhakar Goud and Sai Kumar, who were previously booked under the Narcotic Drugs and Psychotropic Substances (NDPS) Act for illegally manufacturing and selling alprazolam to toddy sellers for spiking the drink.

Sai Kumar Goud and K. Rakesh previously worked in various pharma laboratories and acquired knowledge of the chemicals and manufacturing process of alprazolam. Owing to the demand for adulterated toddy, they started manufacturing alprazolam illegally, the officials explained.

Five factories manufacturing alprazolam have been unearthed in the last one year including at Nagarkurnool DRI, Jinnaram, Cherlapally, Vijayawada and Fisalwadi – while the drug is also being supplied from Pune, Indore, Ratlam and Delhi.

A case has been booked under Section 8(c) r/w 21(c), 22(c), 29 of the NDPS Act-1985.

Related Posts

‘Drug companies in upgrade mode need more time for GMP compliance’: IDMA

New Delhi: A pharma group has sought extension for those production units that have already submitted upgradation plans and can demonstrate execution progress, even as the drug regulatory authority seems…

Obesity treatment drugs to be new growth engine for pharma industry: Sun Pharma

New Delhi: Improving access to new age medicines for obesity and diabetes over the next few years would be a key enabler for the growth of the domestic pharmaceutical industry,…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

‘Drug companies in upgrade mode need more time for GMP compliance’: IDMA

‘Drug companies in upgrade mode need more time for GMP compliance’: IDMA

Obesity treatment drugs to be new growth engine for pharma industry: Sun Pharma

Obesity treatment drugs to be new growth engine for pharma industry: Sun Pharma

National Pharmaceutical Pricing Authority fixes retail price of 37 new drugs

National Pharmaceutical Pricing Authority fixes retail price of 37 new drugs

Massive Drug Bust in Bijnor: CBN Seizes Over 6.5 Lakh Tablets

Massive Drug Bust in Bijnor: CBN Seizes Over 6.5 Lakh Tablets

Sun Pharma unit recalls 17,000-plus bottles of antifungal shampoo in US

Sun Pharma unit recalls 17,000-plus bottles of antifungal shampoo in US

Strides Pharma Science arm New York facility gets 4 USFDA observations

Strides Pharma Science arm New York facility gets 4 USFDA observations